-
1
-
2
Sleeve Gastrectomy in Patients with Type 2 Diabetes: Anthropometric and Cardiometabolic Improvements at 1, 3, 5, 7, and 9 years—Are the Initial Benefits Sustained?
Published 2025“…We appraised the evolution of 20 outcomes at 1, 3, 5, 7, and 9 years.…”
-
3
Characterization of Dse1 a candida albicans cells wall protein. (c2009)
Published 2009Get full text
Get full text
masterThesis -
4
-
5
-
6
-
7
-
8
-
9
Effect of the stretch rate during uniaxial testing on the mechanical properties of prolene
Published 2017Get full text
Get full text
Get full text
Get full text
conferenceObject -
10
Clinical characteristics and treatment outcomes of coats disease in a Saudi Arabian population
Published 2015“…Based on the Shields classification, the eyes were Stage 1 (n = 1, 1%), Stage 2A (n = 7, 7%), Stage 2B (n = 23, 24%), Stage 3A1 (n = 26, 27%), Stage 3A2 (n = 12, 12%), Stage 3B (n = 16, 17%), Stage 4 (n = 11, 11%), and Stage 5 (n = 5, 1%). …”
Get full text
Get full text
Get full text
Get full text
article -
11
-
12
-
13
-
14
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
Published 2024“…The proportion of livebirths occurring in sub-Saharan Africa was forecast to increase to more than half of the world's livebirths in 2100, to 41·3% (39·6–43·1) in 2050 and 54·3% (47·1–59·5) in 2100. The share of livebirths was projected to decline between 2021 and 2100 in most of the six other super-regions—decreasing, for example, in south Asia from 24·8% (23·7–25·8) in 2021 to 16·7% (14·3–19·1) in 2050 and 7·1% (4·4–10·1) in 2100—but was forecast to increase modestly in the north Africa and Middle East and high-income super-regions. …”
Get full text
Get full text
Get full text
article -
15
-
16
-
17
-
18
The role of RhoG in migration and invasion of glioblastoma cells. (c2017)
Published 2017Get full text
Get full text
Get full text
masterThesis -
19
-
20